Evidence map›Paper›PMID 34489986›Full record

ArticleFrontiers in plant science2021

Characterization of

Chase Beathard, Sutton Mooney, Raed Al-Saharin, Aymeric Goyer, Hanjo Hellmann

Open access · goldAbstract read
In one paragraph

Article in Frontiers in plant science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Molecular mechanism ofHorticulture research · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. ACS omega · 2024
    Article
  11. Article
  12. Review
  13. Plants (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Identification of the passion fruit (Frontiers in plant science · 2023
    Article
  16. The Anthocyanin Accumulation RelatedInternational journal of molecular sciences · 2022
    Article
  17. Using CRL3Plant direct · 2022
    Article
  18. The R2R3 MYB Transcription FactorPlants (Basel, Switzerland) · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Chase BeathardSchool of Biological Sciences, Washington State University, Pullman, WA, United States.
Sutton MooneySchool of Biological Sciences, Washington State University, Pullman, WA, United States.
Raed Al-SaharinSchool of Biological Sciences, Washington State University, Pullman, WA, United States.
Aymeric GoyerDepartment of Botany and Plant Pathology, Hermiston Agricultural Research and Extension Center, Oregon State University, Hermiston, OR, United States.
Hanjo HellmannSchool of Biological Sciences, Washington State University, Pullman, WA, United States.
Washington State University · USOregon State University · USTafila Technical University · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid response to environmental changes and abiotic stress to coordinate developmental programs is critical for plants. To accomplish this, plants use the ubiquitin proteasome pathway as a flexible and efficient mechanism to control protein stability and to direct cellular reactions. Here, we show that all three members of the R2R3 S23 MYB transcription factor subfamily, MYB1, MYB25, and MYB109, are degraded by the 26S proteasome, likely facilitated by a CUL3-based E3 ligase that uses MATH-BTB/POZ proteins as substrate adaptors. A detailed description of

Indexed as

abiotic stressBPMCRL3CUL3E3 ligaseMYBS23transcription factor

Identifiers

PMID34489986
PMCPMC8417012
OpenAlexW3194196916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.